The impact of budesonide inhalation suspension for asthma hospitalization: In terms of length of stay, recovery time from symptoms, and hospitalization costs

The impact of budesonide inhalation suspension for asthma hospitalization: In terms of length of stay, recovery time from symptoms, and hospitalization costs

Background: Hospitalization is a major cause of medical expenditure for asthma. Budesonide inhalation suspension (BIS) may assist in reducing asthma-related symptoms in severe asthma exacerbation. However, its effectiveness for hospitalized patients remains poorly known. The objective of this study...

Full description

Bibliographic Details
Main Authors: Keima Ito, Yoshihiro Kanemitsu, Kensuke Fukumitsu, Yoshitsugu Inoue, Hirono Nishiyama, Sayaka Yamamoto, Yuki Kitamura, Ryota Kurokawa, Norihisa Takeda, Satoshi Fukuda, Takehiro Uemura, Tomoko Tajiri, Osamu Takakuwa, Hirotsugu Ohkubo, Masaya Takemura, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Akio Niimi
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Allergology International
Subjects:
Budesonide inhalation suspension
Hospitalization costs
Length of hospital stay
Respiratory infection
Severe asthma exacerbation
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893020300538

Internet

http://www.sciencedirect.com/science/article/pii/S1323893020300538

Similar Items